For providers

Florida Apheresis partners with cardiologists, lipidologists, and primary care physicians across South Florida to provide lipoprotein apheresis for patients who have exhausted standard therapeutic options.

We handle insurance verification, prior authorization, and patient scheduling so your office involvement is minimal. We communicate treatment progress back to you regularly and support co-management of the patient's lipid regimen.

• Elevated Lp(a) (≥60 mg/dL or ≥130 nmol/L) with established ASCVD

• LDL-C not at goal despite maximally tolerated statin + PCSK9 inhibitor therapy

• Diagnosis of familial hypercholesterolemia (homozygous or heterozygous)

• Recurrent cardiovascular events despite optimal medical management

• Statin intolerance with persistently high LDL or Lp(a)

⚠ Important: Patients currently taking ACE inhibitors must discontinue or switch to an ARB or alternative agent prior to starting apheresis to avoid severe bradykinin-mediated hypotension.

Medicare and most major insurers cover lipoprotein apheresis for patients meeting the following criteria:

Group A — Homozygous FH with LDL-C >500 mg/dL

Group B — Heterozygous FH with LDL-C ≥300 mg/dL

Group C — Heterozygous FH with LDL-C ≥70 mg/dL plus documented CAD or PAD

Group D — Heterozygous FH with Lp(a) ≥60 mg/dL (or ≥130 nmol/L) plus documented CAD or PAD

We manage all prior authorization documentation in-house. Contact us to discuss borderline cases  we are happy to assist.

Referring a patient is simple:

📞 Call us: 561-430-3599

📧 Email: info@floridaapheresis.com

📋 Send recent labs and a brief clinical summary  we'll take it from there.

We will contact the patient, verify insurance, and keep you informed throughout their care.